<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.annalsofintensivecare.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Annals of Intensive Care - Latest Articles</title>
        <link>http://www.annalsofintensivecare.com</link>
        <description>The latest research articles published by Annals of Intensive Care</description>
        <dc:date>2013-05-22T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/13" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/12" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/11" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/10" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/9" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/8" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/7" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/6" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/5" />
                                <rdf:li rdf:resource="http://www.annalsofintensivecare.com/content/3/1/4" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/13">
        <title>Does vasopressor therapy have an indication in hemorrhagic shock?</title>
        <description>This review aimed to answer whether the vasopressors are useful at the early phase of hemorrhagic shock. Data were taken from published experimental studies and clinical trials. Published case reports were discarded. A search of electronic database PubMed was conducted using keywords of hemorrhagic shock, vasopressors, vasoconstrictors, norepinephrine, epinephrine, vasopressin. The redundant papers were not included. We identified 15 experimental studies that compared hemorrhagic shock resuscitated with or without vasopressors, three retrospective clinical studies, and one controlled trial. The experimental and clinical studies are discussed in the clinical context, and their strengths as well as limitations are highlighted. There is a strong rationale for a vasopressor support in severe hemorrhagic shock. However, this should be tempered by the risk of excessive vasoconstriction during such hypovolemic state. The experimental models must be analyzed within their own limits and cannot be directly translated into clinical practice. In addition, because of many biases, the results of clinical trials are debatable. Therefore, based on current information, further clinical trials comparing early vasopressor support plus fluid resuscitation versus fluid resuscitation alone are warranted.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/13</link>
                <dc:creator>François Beloncle</dc:creator>
                <dc:creator>Ferhat Meziani</dc:creator>
                <dc:creator>Nicolas Lerolle</dc:creator>
                <dc:creator>Peter Radermacher</dc:creator>
                <dc:creator>Pierre Asfar</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:13</dc:source>
        <dc:date>2013-05-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-13</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-13-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2013-05-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/12">
        <title>Clinical use of lactate monitoring in critically ill patients</title>
        <description>Increased blood lactate levels (hyperlactataemia) are common in critically ill patients. Although frequently used to diagnose inadequate tissue oxygenation, other processes not related to tissue oxygenation may increase lactate levels. Especially in critically ill patients, increased glycolysis may be an important cause of hyperlactataemia. Nevertheless, the presence of increased lactate levels has important implications for the morbidity and mortality of the hyperlactataemic patients. Although the term lactic acidosis is frequently used, a significant relationship between lactate and pH only exists at higher lactate levels. The term lactate associated acidosis is therefore more appropriate. Two recent studies have underscored the importance of monitoring lactate levels and adjust treatment to the change in lactate levels in early resuscitation. As lactate levels can be measured rapidly at the bedside from various sources, structured lactate measurements should be incorporated in resuscitation protocols.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/12</link>
                <dc:creator>Jan Bakker</dc:creator>
                <dc:creator>Maarten Nijsten</dc:creator>
                <dc:creator>Tim Jansen</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:12</dc:source>
        <dc:date>2013-05-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-12</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-12-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2013-05-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/11">
        <title>Acute respiratory distress syndrome: prevention and early recognition</title>
        <description>Acute respiratory distress syndrome (ARDS) is common in critically ill patients admitted to intensive care units (ICU). ARDS results in increased use of critical care resources and healthcare costs, yet the overall mortality associated with these conditions remains high. Research focusing on preventing ARDS and identifying patients at risk of developing ARDS is necessary to develop strategies to alter the clinical course and progression of the disease. To date, few strategies have shown clear benefits. One of the most important obstacles to preventive interventions is the difficulty of identifying patients likely to develop ARDS. Identifying patients at risk and implementing prevention strategies in this group are key factors in preventing ARDS. This review will discuss early identification of at-risk patients and the current prevention strategies.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/11</link>
                <dc:creator>Candelaria de Haro</dc:creator>
                <dc:creator>Ignacio Martin-Loeches</dc:creator>
                <dc:creator>Eva Torrents</dc:creator>
                <dc:creator>Antonio Artigas</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:11</dc:source>
        <dc:date>2013-04-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-11</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-11-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2013-04-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/10">
        <title>Adverse events during intrahospital transport of critically ill patients: incidence and risk factors</title>
        <description>Background:
Transport of critically ill patients for diagnostic or therapeutic procedures is at risk of complications. Adverse events during transport are common and may have significant consequences for the patient. The objective of the study was to collect prospectively adverse events that occurred during intrahospital transports of critically ill patients and to determine their risk factors.
Methods:
This prospective, observational study of intrahospital transport of consecutively admitted patients with mechanical ventilation was conducted in a 38-bed intensive care unit in a university hospital from May 2009 to March 2010.
Results:
Of 262 transports observed (184 patients), 120 (45.8%) were associated with adverse events. Risk factors were ventilation with positive end-expiratory pressure &gt;6 cmH2O, sedation before transport, and fluid loading for intrahospital transports. Within these intrahospital transports with adverse events, 68 (26% of all intrahospital transports) were associated with an adverse event affecting the patient. Identified risk factors were: positive end-expiratory pressure &gt;6 cmH2O, and treatment modification before transport. In 44 cases (16.8% of all intrahospital transports), adverse event was considered serious for the patient. In our study, adverse events did not statistically increase ventilator-associated pneumonia, time spent on mechanical ventilation, or length of stay in the intensive care unit.
Conclusions:
This study confirms that the intrahospital transports of critically ill patients leads to a significant number of adverse events. Although in our study adverse events have not had major consequences on the patient stay, efforts should be made to decrease their incidence.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/10</link>
                <dc:creator>Erika Parmentier-Decrucq</dc:creator>
                <dc:creator>Julien Poissy</dc:creator>
                <dc:creator>Raphaël Favory</dc:creator>
                <dc:creator>Saad Nseir</dc:creator>
                <dc:creator>Thierry Onimus</dc:creator>
                <dc:creator>Mary-Jane Guerry</dc:creator>
                <dc:creator>Alain Durocher</dc:creator>
                <dc:creator>Daniel Mathieu</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:10</dc:source>
        <dc:date>2013-04-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-10</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-10-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2013-04-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/9">
        <title>The pain, agitation, and delirium practice guidelines for adult critically ill patients: a post-publication perspective</title>
        <description>The recently published Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit differ from earlier guidelines in the following ways: literature searches were performed in eight databases by a professional librarian; psychometric validation of assessment scales was considered in their recommendation; discrepancies in recommendation votes by guideline panel members are available in online supplements; and all recommendations were made exclusively on the basis of evidence available until December of 2010. Pain recognition and management remains challenging in the critically ill. Patient outcomes improve with routine pain assessment, use of co-analgesics and administration as well as dose adjustment of opiates to patient needs. Thoracic epidurals help ease patients undergoing abdominal aortic surgery. Little data exists to guide clinicians as to the type or dose of co-analgesics; no opiate choice is associated with better patient outcomes. Lighter or no sedation is beneficial, and interruption is desirable in patients who require deep sedation for specific pathologic states. Delirium screening is probably useful; no treatment modality can be unequivocally recommended, and the benefit of prophylaxis is established only for early mobilization. The details of these recommendations, as well as more recent publications that complement the guidelines, are provided in this commentary.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/9</link>
                <dc:creator>Yoanna Skrobik</dc:creator>
                <dc:creator>Gerald Chanques</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:9</dc:source>
        <dc:date>2013-04-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-9</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-9-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2013-04-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/8">
        <title>An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury</title>
        <description>Background:
Because neither the incidence and risk factors for rhabdomyolysis in the ICU nor the dynamics of its main complication, i.e., rhabdomyolysis-induced acute kidney injury (AKI) are well known, we retrospectively studied a large population of adult ICU patients (n&#8201;=&#8201;1,769).
Methods:
CK and sMb (serum myoglobin) and uMb (urinary myoglobin) were studied as markers of rhabdomyolysis and AKI (RIFLE criteria). Hemodialysis and mortality were used as outcome variables.
Results:
Prolonged surgery, trauma, and vascular occlusions are associated with increasing CK values. CK correlates with sMb (p&#8201;&lt;&#8201;0.001) and peaks significantly later than sMb or uMb.The logistic regression showed a positive correlation between CK and the development of AKI, with an OR of 2.21. Univariate logistic regression suggests that elevations of sMb and uMb are associated with the development of AKI, with odds ratios of 7.87 and 1.61 respectively. The ROC curve showed that for all three markers a significant correlation with AKI, for sMb with the greatest area under the curve. The best cutoff values for prediction of AKI were CK&#8201;&gt;&#8201;773 U/l; sMb&#8201;&gt;&#8201;368&#160;&#956;g/l and uMb&#8201;&gt;&#8201;38&#160;&#956;g/l respectively.
Conclusions:
Because it also has extrarenal elimination kinetics, our data suggest that measuring myoglobin in patients at risk for rhabdomyolysis in the ICU may be useful.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/8</link>
                <dc:creator>Esmael El-Abdellati</dc:creator>
                <dc:creator>Michiel Eyselbergs</dc:creator>
                <dc:creator>Halil Sirimsi</dc:creator>
                <dc:creator>Viviane Van Hoof</dc:creator>
                <dc:creator>Kristien Wouters</dc:creator>
                <dc:creator>Walter Verbrugghe</dc:creator>
                <dc:creator>Philippe Jorens</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:8</dc:source>
        <dc:date>2013-03-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-8</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-8-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2013-03-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/7">
        <title>Management of children with sepsis and septic shock: a survey among pediatric intensivists of the R&#233;seau M&#232;re-Enfant de la Francophonie</title>
        <description>Background:
Pediatric sepsis represents an important cause of mortality in pediatric intensive care units (PICU). Although adherence to published guidelines for the management of severe sepsis patients is known to lower mortality, actual adherence to these recommendations is low. The aim of this study was to describe the initial management of pediatric patients with severe sepsis, as well as to describe the main barriers to the adherence to current guidelines on management of these patients.
Methods:
A survey using a case scenario to assess the management of a child with severe sepsis was designed and sent out to all PICU medical directors of the 20 institutions member of the &#8220;R&#233;seau M&#232;re- Enfant de la Francophonie&#8221;. Participants were asked to describe in detail the usual management of these patients in their institution with regard to investigations, fluid and catecholamine management, intubation, and specific treatments. Participants were also asked to identify the main barriers to the application of the Surviving Sepsis Campaign guidelines in their center.
Results:
Twelve PICU medical directors answered the survey. Only two elements of the severe sepsis bundles had a low stated compliance rate: &#8220;maintain adequate central venous pressure&#8221; and &#8220;glycemic control&#8221; had a stated compliance of 8% and 25% respectively. All other elements of the bundles had a reported compliance of over 90%. Furthermore, the most important barriers to the adherence to Surviving Sepsis Campaign guidelines were the unavailability of continuous central venous oxygen saturation (ScvO2) monitoring and the absence of a locally written protocol.
Conclusions:
In this survey, pediatric intensivists reported high adherence to the current recommendations in the management of pediatric severe sepsis regarding antibiotic administration, rapid fluid resuscitation, and administration of catecholamines and steroids, if needed. Technical difficulties in obtaining continuous ScvO2 monitoring and absence of a locally written protocol were the main barriers to the uniform application of current guidelines. We believe that the development of locally written protocols and of specialized teams could add to the achievement of the goal that every child in sepsis should be treated according to the latest evidence to heighten his chances of survival.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/7</link>
                <dc:creator>Miriam Santschi</dc:creator>
                <dc:creator>Francis Leclerc</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:7</dc:source>
        <dc:date>2013-03-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-7</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-7-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2013-03-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/6">
        <title>Cumulative lactate and hospital mortality in ICU patients</title>
        <description>Background:
Both hyperlactatemia and persistence of hyperlactatemia have been associated with bad outcome. We compared lactate and lactate-derived variables in outcome prediction.
Methods:
Retrospective observational study. Case records from 2,251 consecutive intensive care unit (ICU) patients admitted between 2001 and 2007 were analyzed. Baseline characteristics, all lactate measurements, and in-hospital mortality were recorded. The time integral of arterial blood lactate levels above the upper normal threshold of 2.2 mmol/L (lactate-time-integral), maximum lactate (max-lactate), and time-to-first-normalization were calculated. Survivors and nonsurvivors were compared and receiver operating characteristic (ROC) analysis were applied.
Results:
A total of 20,755 lactate measurements were analyzed. Data are srpehown as median [interquartile range]. In nonsurvivors (n = 405) lactate-time-integral (192 [0&#8211;1881] min&#183;mmol/L) and time-to-first normalization (44.0 [0&#8211;427] min) were higher than in hospital survivors (n = 1846; 0 [0&#8211;134] min&#183;mmol/L and 0 [0&#8211;75] min, respectively; all p &lt; 0.001). Normalization of lactate &lt;6 hours after ICU admission revealed better survival compared with normalization of lactate &gt;6 hours (mortality 16.6% vs. 24.4%; p &lt; 0.001). AUC of ROC curves to predict in-hospital mortality was the largest for max-lactate, whereas it was not different among all other lactate derived variables (all p &gt; 0.05). The area under the ROC curves for admission lactate and lactate-time-integral was not different (p = 0.36).
Conclusions:
Hyperlactatemia is associated with in-hospital mortality in a heterogeneous ICU population. In our patients, lactate peak values predicted in-hospital mortality equally well as lactate-time-integral of arterial blood lactate levels above the upper normal threshold.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/6</link>
                <dc:creator>Paul van Beest</dc:creator>
                <dc:creator>Lukas Brander</dc:creator>
                <dc:creator>Sebastiaan Jansen</dc:creator>
                <dc:creator>Johannes Rommes</dc:creator>
                <dc:creator>Michaël Kuiper</dc:creator>
                <dc:creator>Peter Spronk</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:6</dc:source>
        <dc:date>2013-02-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-6</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-6-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2013-02-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/5">
        <title>Evaluation of the depth of sedation in an intensive care unit based on the photo motor reflex variations measured by video pupillometry</title>
        <description>Background:
Evaluating depth of sedation in the intensive care unit (ICU) is crucial for the management of mechanically ventilated patients but can be challenging in some situations. Because the depth of hypnosis is correlated with the decrease in photomotor reflex (PMR), we suggest using pupillometric video as an automated, noninvasive, simple, and reproducible technique to evaluate the depth of sedation in ICU patients. We compare the effectiveness of this procedure to the bispectral index (BIS).
Methods:
Thirty-one patients requiring sedation and ventilation were included in this monocentric, observational study. The posology of hypnotics and morphinics were based on the Richmond Agitation and Sedation Scale (RASS). PMR was measured by the Neurolight&#174; (IDMED) system and BIS value by BIS Vista&#174; (Anandic Medical Systems). RASS, PMR, and BIS were measured three times daily in all patients. Data acquired by pupillometric video included variation in pupillary diameter (&#916;PD), latency time (LT), and maximal speed of pupillary constriction (Vmax). These parameters were analyzed after having classified BIS values in three groups (&lt;40 heavy sedation; 40 &#8804; BIS &#8804; 60 acceptable sedation; &gt;60 light sedation). Exclusion criteria were neurological or ophthalmologic pathologies that could interfere with PMR.
Results:
There was a significant difference in Vmax and &#916;PD between the BIS &lt; 40 group and 40 &#8804; BIS &#8804; 60 groups (p &lt; 0.0001 for each) and between the BIS &lt; 40 and BIS &gt; 60 groups (p &lt; 0.0001 for each). There were no significant differences in Vmax and &#916;PD between the 40 &#8804; BIS &#8804; 60 and BIS &gt; 60 groups. There was no correlation between any of the BIS groups and LT.
Conclusions:
Vmax and &#916;PD seem to be relevant criteria compared with the BIS and the RASS. Pupillometric video monitoring of depth of sedation could be beneficial in ICU patients, especially for those under myorelaxant drugs, where no clinical evaluation of sedation is possible.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/5</link>
                <dc:creator>Ouri Rouche</dc:creator>
                <dc:creator>Aurore Wolak-Thierry</dc:creator>
                <dc:creator>Quentin Destoop</dc:creator>
                <dc:creator>Lucas Milloncourt</dc:creator>
                <dc:creator>Thierry Floch</dc:creator>
                <dc:creator>Pascal Raclot</dc:creator>
                <dc:creator>Damien Jolly</dc:creator>
                <dc:creator>Joël Cousson</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:5</dc:source>
        <dc:date>2013-02-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-5</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-5-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2013-02-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.annalsofintensivecare.com/content/3/1/4">
        <title>Specific antioxidant properties of human serum albumin</title>
        <description>Human serum albumin (HSA) has been used for a long time as a resuscitation fluid in critically ill patients. It is known to exert several important physiological and pharmacological functions. Among them, the antioxidant properties seem to be of paramount importance as they may be implied in the potential beneficial effects that have been observed in the critical care and hepatological settings. The specific antioxidant functions of the protein are closely related to its structure. Indeed, they are due to its multiple ligand-binding capacities and free radical-trapping properties. The HSA molecule can undergo various structural changes modifying its conformation and hence its binding properties and redox state. Such chemical modifications can occur during bioprocesses and storage conditions of the commercial HSA solutions, resulting in heterogeneous solutions for infusion. In this review, we explore the mechanisms that are responsible for the specific antioxidant properties of HSA in its native form, chemically modified forms, and commercial formulations. To conclude, we discuss the implication of this recent literature for future clinical trials using albumin as a drug and for elucidating the effects of HSA infusion in critically ill patients.</description>
        <link>http://www.annalsofintensivecare.com/content/3/1/4</link>
                <dc:creator>Myriam Taverna</dc:creator>
                <dc:creator>Anne-Lise Marie</dc:creator>
                <dc:creator>Jean-Paul Mira</dc:creator>
                <dc:creator>Bertrand Guidet</dc:creator>
                <dc:source>Annals of Intensive Care 2013, null:4</dc:source>
        <dc:date>2013-02-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/2110-5820-3-4</dc:identifier>
                                <prism:require>/content/figures/2110-5820-3-4-toc.gif</prism:require>
                <prism:publicationName>Annals of Intensive Care</prism:publicationName>
        <prism:issn>2110-5820</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2013-02-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
